Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Avishay Sella

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
Urology|March 1, 2008
Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancerAvishay Sella, Amnon Zisman, Svetlana Kovel, et al.
The Journal of Urology|January 17, 2002
Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled studyDan Leibovici, Amnon Zisman, Yoram I Siegel, et al.
Clinical Genitourinary Cancer|September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With SunitinibAvishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Anti-Cancer Drugs|March 21, 2013
Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to boneEduard Vrdoljak, Brian Rini, Manuela Schmidinger, et al.
International Journal of Cancer|March 13, 2012
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patientsAyelet Avraham, Ronit Uhlmann, Aino Shperber, et al.
The Journal of Urology|September 18, 2007
The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgeryOrit Raz, Sonia Mendlovic, Dan Leibovici, et al.
The Prostate|December 17, 2013
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxelAvivit Peer, Maya Gottfried, Victoria Sinibaldi, et al.
Future Oncology (London, England)|June 30, 2015
Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysisEduard Vrdoljak, Martin Gore, Sophie Leyman, et al.
Epigenetics|January 20, 2010
A similar cell-specific pattern of HOXA methylation in normal and in cancer tissuesAyelet Avraham, Judith Sandbank, Nirit Yarom, et al.
Clinical Genitourinary Cancer|May 11, 2019
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS TrialSergio Bracarda, Aristotelis Bamias, Jochen Casper, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
Urology|March 1, 2008
Neoadjuvant chemohormonal therapy in poor-prognosis localized prostate cancerAvishay Sella, Amnon Zisman, Svetlana Kovel, et al.
The Journal of Urology|January 17, 2002
Local anesthesia for prostate biopsy by periprostatic lidocaine injection: a double-blind placebo controlled studyDan Leibovici, Amnon Zisman, Yoram I Siegel, et al.
Clinical Genitourinary Cancer|September 18, 2016
Heterogeneity of Patients With Intermediate-Prognosis Metastatic Renal Cell Carcinoma Treated With SunitinibAvishay Sella, M Dror Michaelson, Ewa Matczak, et al.
Anti-Cancer Drugs|March 21, 2013
Bisphosphonates and vascular endothelial growth factor-targeted drugs in the treatment of patients with renal cell carcinoma metastatic to boneEduard Vrdoljak, Brian Rini, Manuela Schmidinger, et al.
International Journal of Cancer|March 13, 2012
Serum DNA methylation for monitoring response to neoadjuvant chemotherapy in breast cancer patientsAyelet Avraham, Ronit Uhlmann, Aino Shperber, et al.
The Journal of Urology|September 18, 2007
The prevalence of malignancy in satellite renal lesions and its surgical implication during nephron sparing surgeryOrit Raz, Sonia Mendlovic, Dan Leibovici, et al.
The Prostate|December 17, 2013
Comparison of abiraterone acetate versus ketoconazole in patients with metastatic castration resistant prostate cancer refractory to docetaxelAvivit Peer, Maya Gottfried, Victoria Sinibaldi, et al.
Future Oncology (London, England)|June 30, 2015
Bisphosphonates in patients with renal cell carcinoma and bone metastases: a sunitinib global expanded-access trial subanalysisEduard Vrdoljak, Martin Gore, Sophie Leyman, et al.
Epigenetics|January 20, 2010
A similar cell-specific pattern of HOXA methylation in normal and in cancer tissuesAyelet Avraham, Judith Sandbank, Nirit Yarom, et al.
Clinical Genitourinary Cancer|May 11, 2019
Is Axitinib Still a Valid Option for mRCC in the Second-Line Setting? Prognostic Factor Analyses From the AXIS TrialSergio Bracarda, Aristotelis Bamias, Jochen Casper, et al.
Pageof 5